View of Urinary Glucose as a Potential Mediator of Infection Risk in Type 2 Diabetes Treated with SGLT2 Inhibitors: Evidence from a Prospective Cohort Study of Immune-metabolic Crosstalk

Return to Article Details Urinary Glucose as a Potential Mediator of Infection Risk in Type 2 Diabetes Treated with SGLT2 Inhibitors: Evidence from a Prospective Cohort Study of Immune-metabolic Crosstalk Download Download PDF